1 Followers on Owler

COVAXX



COVAXX is a Private company. COVAXX has 1 followers on Owler. COVAXX has an estimated revenue of <$1M and an estimate of less <10 employees.

CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Founded:

2020

Status:

PrivateIndependent Company

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Sector

Update Industry

COVAXX Acquisitions

No recent acquisitions found related to COVAXX

COVAXX Funding History

No recent funding data found related to COVAXX

COVAXX Investments

No recent investments found related to COVAXX

COVAXX News

January 24, 2021Medical Buyer

COVAXX gets FDA EUA status for UBI SARS-CoV-2 ELISA antibody test

United Biomedical subsidiary COVAXX has secured an emergency use authorisation (EUA) from the US Food... See more »
January 22, 2021NS Medical Devices

COVAXX gets FDA EUA status for UBI SARS-CoV-2 ELISA antibody test

The post COVAXX gets FDA EUA status for UBI SARS-CoV-2 ELISA antibody test appeared first on NS Medic... See more »
January 8, 2021FinanzNachrichten

COVAXX Announces Early Design and Testing of New Vaccine Candidate to Address Mutations in SARS-CoV-2

New York, New York--(Newsfile Corp. - January 8, 2021) - COVAXX, a U.S. company developing a multitop... See more »
December 28, 2020PharmaLeaders

Aurobindo, COVAXX sign deal to develop Covid-19 vaccine UB-612

UB-612 is said to be the first multitope, synthetic peptide-based Covid-19 vaccine candidate. Under t... See more »
December 24, 2020FinanzNachrichten

Aurobindo Pharma Signs Deal To Develop & Commercialize COVAXX' COVID-19 Vaccine For India & UNICEF

NEW DELHI (dpa-AFX) - Aurobindo Pharma said it has obtained the exclusive rights to develop, manufact... See more »
December 24, 2020India Infoline

Aurobindo Pharma and COVAXX in license agreement to develop UB-612 vaccine for Coronavirus; Eyes capacity of 480M doses by June 2021

At present, COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate.... See more »
November 30, 2020FinanzNachrichten

COVAXX to Participate in Opening Keynote Panel with FDA and WHO experts on SARS-CoV-2 at the World Vaccine & Immunotherapy Conference West Coast December 1, 2020

Hauppauge, New York--(Newsfile Corp. - November 30, 2020) - COVAXX, a U.S. company developing a synth... See more »

COVAXX Press Releases

Social Media

COVAXX Headquarters

1717 Main Street Suite 3388

Dallas, Texas75201

Driving Directions »

Trending Companies

COVAXX Summary

ABOUT

Overview

COVAXX was founded in 2020. COVAXX's headquarters is located in Dallas, Texas, USA 75201. ...

Website

covaxx.com

Frequently Asked Questions about COVAXX

  1. When was COVAXX founded?

    COVAXX was founded in 2020
  2. How much revenue does COVAXX generate?

    COVAXX generates $ < 1M in revenue
  3. How much funding does COVAXX have?

    COVAXX has historically raised $0 in funding
  1. Where is COVAXX's headquarters?

    COVAXX's headquarters is in Dallas Texas, USA
  2. How many employees does COVAXX have?

    COVAXX has 0 employees